Jakubowiak, A. J., Dytfeld, D., Griffith, K. A., Lebovic, D., Vesole, D. H., Jagannath, S., . . . Vij, R. (2012). A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma. Blood.
استشهاد بنمط شيكاغوJakubowiak, Andrzej J., et al. "A Phase 1/2 Study of Carfilzomib in Combination With Lenalidomide and Low-dose Dexamethasone As a Frontline Treatment for Multiple Myeloma." Blood 2012.
MLA استشهادJakubowiak, Andrzej J., et al. "A Phase 1/2 Study of Carfilzomib in Combination With Lenalidomide and Low-dose Dexamethasone As a Frontline Treatment for Multiple Myeloma." Blood 2012.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.